Case reportNivolumab-associated vitiligo-like depigmentation in a patient with acute myeloid leukemia: A novel finding
Under a Creative Commons license
open access
Key words
adverse events
immunomodulators
immunotherapy
nivolumab
programmed cell death–1
vitiligo
Abbreviations used
AML
acute myeloid leukemia
irAEs
immune-related adverse events
PD-1
programmed cell death–1
Cited by (0)
Funding sources: None.
Conflicts of interest: None declared.
© 2016 Elsevier Inc.